• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

带状疱疹后持续性疼痛相关危险因素的识别。

The identification of risk factors associated with persistent pain following herpes zoster.

作者信息

Whitley R J, Shukla S, Crooks R J

机构信息

Department of Pediatrics, Microbiology, and Medicine, University of Alabama at Birmingham 35233, USA.

出版信息

J Infect Dis. 1998 Nov;178 Suppl 1:S71-5. doi: 10.1086/514274.

DOI:10.1086/514274
PMID:9852979
Abstract

Demographic and clinical characteristics of patients with herpes zoster at the time of presentation predict the duration and severity of pain on long-term follow-up. Analyses by Cox's proportional hazard models of six databases from controlled trials of antiviral drugs (total subjects = 2367) identified covariates for zoster-associated pain; all tests for significance were two-sided. Age strongly influenced pain outcome: patients > or = 50 years old were significantly more likely to have prolonged zoster-associated pain compared with those < 30 years old. Patients with prodromal symptoms or moderate or severe pain at presentation were also more likely to experience prolonged zoster-associated pain. Neither time to initiating treatment after rash onset nor sex of patient influenced pain outcome. Advancing age, prodromal symptoms, and acute pain severity at presentation predicted those individuals most at risk of prolonged pain and postherpetic neuralgia. When two or more of these factors were present, the risk of persistent pain was increased.

摘要

带状疱疹患者就诊时的人口统计学和临床特征可预测长期随访时疼痛的持续时间和严重程度。通过对六个来自抗病毒药物对照试验数据库(总受试者 = 2367)进行Cox比例风险模型分析,确定了带状疱疹相关性疼痛的协变量;所有显著性检验均为双侧检验。年龄对疼痛结局有强烈影响:与年龄小于30岁的患者相比,年龄大于或等于50岁的患者发生带状疱疹相关性疼痛延长的可能性显著更高。就诊时有前驱症状或中度或重度疼痛的患者也更有可能经历带状疱疹相关性疼痛延长。皮疹发作后开始治疗的时间和患者性别均未影响疼痛结局。年龄增长、前驱症状和就诊时的急性疼痛严重程度可预测那些最有可能发生疼痛延长和带状疱疹后神经痛的个体。当存在两个或更多这些因素时,持续性疼痛的风险会增加。

相似文献

1
The identification of risk factors associated with persistent pain following herpes zoster.带状疱疹后持续性疼痛相关危险因素的识别。
J Infect Dis. 1998 Nov;178 Suppl 1:S71-5. doi: 10.1086/514274.
2
Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients.带状疱疹后神经痛:泛昔洛韦、年龄、皮疹严重程度及急性疼痛对带状疱疹患者的影响
J Infect Dis. 1998 Nov;178 Suppl 1:S76-80. doi: 10.1086/514260.
3
A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic.一项针对三级皮肤科门诊转诊诊所中带状疱疹临床表现及转归的回顾性研究。
Int J Dermatol. 1997 Sep;36(9):667-72. doi: 10.1046/j.1365-4362.1997.00241.x.
4
Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.使用 S-LANSS(一种用于筛查神经性疼痛的工具)预测急性带状疱疹事件后患者的带状疱疹后神经痛:一项单中心、12 个月、前瞻性队列研究。
J Pain. 2014 Feb;15(2):149-56. doi: 10.1016/j.jpain.2013.10.006. Epub 2013 Oct 26.
5
Chronic neuralgia incidence following local anesthetic therapy for herpes zoster.带状疱疹局部麻醉治疗后的慢性神经痛发生率
Arch Dermatol. 1984 Jun;120(6):747-50.
6
A 9 year follow up of post herpetic neuralgia and predisposing factors in elderly patients following herpes zoster.带状疱疹后神经痛的 9 年随访及老年带状疱疹患者的易患因素。
J Infect. 2009 Dec;59(6):416-20. doi: 10.1016/j.jinf.2009.09.008. Epub 2009 Sep 17.
7
[Pain treatment of herpes zoster].[带状疱疹的疼痛治疗]
Nihon Rinsho. 2000 Apr;58(4):951-6.
8
How to measure and reduce the burden of zoster-associated pain.如何测量和减轻带状疱疹相关性疼痛的负担。
Scand J Infect Dis Suppl. 1996;100:55-8.
9
Vaccination: a new option to reduce the burden of herpes zoster.接种疫苗:减轻带状疱疹负担的新选择。
Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32.
10
Herpes zoster and postherpetic neuralgia: prevention and management.带状疱疹及带状疱疹后神经痛:预防与管理
Am Fam Physician. 2005 Sep 15;72(6):1075-80.

引用本文的文献

1
Incidence and risk factors for herpes zoster after adult liver transplantation.成人肝移植后带状疱疹的发病率及危险因素
Ann Surg Treat Res. 2019 Feb;96(2):95-99. doi: 10.4174/astr.2019.96.2.95. Epub 2018 Jan 30.
2
Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.意大利带状疱疹及带状疱疹后神经痛的发病率:一项基于人群的3年研究结果
Hum Vaccin Immunother. 2017 Feb;13(2):399-404. doi: 10.1080/21645515.2017.1264834. Epub 2016 Dec 7.
3
Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study.
作为带状疱疹并发症预测指标的初始发病部位:一项全国性队列研究。
PLoS One. 2016 Oct 6;11(10):e0164019. doi: 10.1371/journal.pone.0164019. eCollection 2016.
4
Herpes Zoster: the rationale for the introduction of vaccination in Italy.带状疱疹:意大利引入疫苗接种的基本原理。
J Prev Med Hyg. 2015 Jun 10;56(1):E33-6.
5
A systematic review and meta-analysis of risk factors for postherpetic neuralgia.带状疱疹后神经痛危险因素的系统评价与荟萃分析。
Pain. 2016 Jan;157(1):30-54. doi: 10.1097/j.pain.0000000000000307.
6
WITHDRAWN: Topical lidocaine for the treatment of postherpetic neuralgia.撤回:外用利多卡因治疗带状疱疹后神经痛。
Cochrane Database Syst Rev. 2013 Oct 28;2013(10):CD004846. doi: 10.1002/14651858.CD004846.pub3.
7
The placebo response: relationship to outcomes in trials of postherpetic neuralgia.安慰剂反应:与疱疹后神经痛试验结果的关系。
Clin Drug Investig. 2010;30(11):739-48. doi: 10.2165/11584300-000000000-00000.
8
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.带状疱疹及其后遗神经痛对生活质量的影响。
BMC Med. 2010 Jun 21;8:37. doi: 10.1186/1741-7015-8-37.
9
Prevention strategies for herpes zoster and post-herpetic neuralgia.带状疱疹和疱疹后神经痛的预防策略。
J Clin Virol. 2010 May;48 Suppl 1(Suppl 1):S14-9. doi: 10.1016/S1386-6532(10)70004-4.
10
Factors contributing to pain chronicity.导致疼痛慢性化的因素。
Curr Pain Headache Rep. 2009 Feb;13(1):7-11. doi: 10.1007/s11916-009-0003-3.